169 related articles for article (PubMed ID: 1360276)
21. 60-Hz electric fields inhibit protein kinase C activity and multidrug resistance gene (MDR1) up-regulation.
Walter RJ; Shtil AA; Roninson IB; Holian O
Radiat Res; 1997 Mar; 147(3):369-75. PubMed ID: 9052685
[TBL] [Abstract][Full Text] [Related]
22. Regulation of prolactin receptor expression by the tumour promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human breast cancer cells.
Ormandy CJ; Lee CS; Kelly PA; Sutherland RL
J Cell Biochem; 1993 May; 52(1):47-56. PubMed ID: 8320275
[TBL] [Abstract][Full Text] [Related]
23. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
24. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
25. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
Chaudhary PM; Roninson IB
J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
[TBL] [Abstract][Full Text] [Related]
26. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells.
Chambers TC; Zheng B; Kuo JF
Mol Pharmacol; 1992 Jun; 41(6):1008-15. PubMed ID: 1377325
[TBL] [Abstract][Full Text] [Related]
27. Multidrug resistance gene (P-glycoprotein) expression in the human fetus.
van Kalken CK; Giaccone G; van der Valk P; Kuiper CM; Hadisaputro MM; Bosma SA; Scheper RJ; Meijer CJ; Pinedo HM
Am J Pathol; 1992 Nov; 141(5):1063-72. PubMed ID: 1359789
[TBL] [Abstract][Full Text] [Related]
28. The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance.
Utz I; Hofer S; Regenass U; Hilbe W; Thaler J; Grunicke H; Hofmann J
Int J Cancer; 1994 Apr; 57(1):104-10. PubMed ID: 7908658
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
Miyamoto K; Inoko K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M
Cancer Res; 1993 Apr; 53(7):1555-9. PubMed ID: 8095855
[TBL] [Abstract][Full Text] [Related]
30. Differential modulation of P-glycoprotein transport by protein kinase inhibition.
Bates SE; Lee JS; Dickstein B; Spolyar M; Fojo AT
Biochemistry; 1993 Sep; 32(35):9156-64. PubMed ID: 7690250
[TBL] [Abstract][Full Text] [Related]
31. MDR1 expression in human leukemia-lymphoma cell lines.
Metge K; Steube K; Uphoff CC; Gignac SM; Drexler HG
Leukemia; 1993 Jun; 7(6):896-7. PubMed ID: 8099136
[TBL] [Abstract][Full Text] [Related]
32. Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes.
Preudhomme C; Lepelley P; Vachee A; Soenen V; Quesnel B; Cosson A; Fenaux P
Leukemia; 1993 Nov; 7(11):1888-90. PubMed ID: 7901457
[TBL] [Abstract][Full Text] [Related]
33. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells.
Zhao JY; Ikeguchi M; Eckersberg T; Kuo MT
Endocrinology; 1993 Aug; 133(2):521-8. PubMed ID: 8102093
[TBL] [Abstract][Full Text] [Related]
34. Multidrug resistance gene (MDR1) expression in human brain tumors.
Nabors MW; Griffin CA; Zehnbauer BA; Hruban RH; Phillips PC; Grossman SA; Brem H; Colvin OM
J Neurosurg; 1991 Dec; 75(6):941-6. PubMed ID: 1682428
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of the MDR1 (multidrug resistance) gene-activating agents on protein kinase C: evidence for redundancy of mechanisms of acquired MDR in leukemia cells.
Shtil AA; Ktitorova OV; Kakpakova ES; Holian O
Leuk Lymphoma; 2000 Dec; 40(1-2):191-5. PubMed ID: 11426620
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
Noonan KE; Beck C; Holzmayer TA; Chin JE; Wunder JS; Andrulis IL; Gazdar AF; Willman CL; Griffith B; Von Hoff DD; Roninson IB
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7160-4. PubMed ID: 1976252
[TBL] [Abstract][Full Text] [Related]
37. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
38. A two-dimensional model of cell movement. Well differentiated human rectal adenocarcinoma cells move as coherent sheets upon TPA stimulation.
Nabeshima K; Komada N; Inoue T; Koono M
Pathol Res Pract; 1995 Feb; 191(1):76-83. PubMed ID: 7651936
[TBL] [Abstract][Full Text] [Related]
39. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1.
Spitaler M; Utz I; Hilbe W; Hofmann J; Grunicke HH
Biochem Pharmacol; 1998 Oct; 56(7):861-9. PubMed ID: 9774148
[TBL] [Abstract][Full Text] [Related]
40. The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo.
Roninson IB
Biochem Pharmacol; 1992 Jan; 43(1):95-102. PubMed ID: 1346497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
